The reporting of Traits, Treatment and Germplasm is a difficult and cumbersome process for manufacturers, distributors and retailers. Each Germplasm manufacturer (defined as Company who has the rights to specific germplasm) has different ways that they want the reporting and the definition of terms varies between manufacturers. Manufacturers reporting to other manufacturers have not always been consistent or timely.  In addition, distributors and retailers need to report one single sale to multiple manufacturers.  Having the technology to complete the multiple reporting has been a barrier.

By standardizing the format, process and mechanism of how trait, treatment and germplasm is reported to manufacturers will require less labor intensive processes and a more consistent and timely reporting of the information for both manufacturers and distributors/retailers.

Updates: 

GTTR Project Board is planning to reinvigorate the project to determine the “go forward” plan for this project.  An open forum was scheduled at the CCP meeting on Wednesday, 6/16 (8:30 – 10 am) and the board invited all attendees to attend (including service providers as there may opportunity for them to participate). In addition, a group of members met on Tuesday evening, 6/15 to discuss the business use case for the Seed Treatment process.